Early outcomes of transurethral en bloc resection of bladder tumor for non-muscle invasive bladder cancer at 108 Military Central Hospital

  • Nguyễn Thanh Tuấn Bệnh viện Trung ương Quân đội 108
  • Trần Đức Dũng Bệnh viện Trung ương Quân đội 108
  • Hoàng Đại Phú Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

Non-muscle invasive bladder cancer, en bloc resection, transurethral resection, ERBT, VI-RADS.

Abstract

Objective: To describe some clinical, paraclinical characteristics and evaluate early outcomes of transurethral en bloc resection of bladder tumor (ERBT) for non-muscle invasive bladder cancer (NMIBC) at 108 Military Central Hospital. Subject and method: A retrospective-prospective descriptive study of 48 NMIBC patients undergoing ERBT from December 2024 to March 2026. Result: Mean age 64.2 ± 13.9 years (27-86), male-to-female ratio 2.7:1. Gross hematuria was the most common presentation (45.8%). On MRI, VI-RADS ≥ 3 accounted for 57.9%, yet all were confirmed non-muscle invasive on histopathology. Mean operative time was 17.1 ± 3.9 minutes. Intraoperative complications: Obturator nerve reflex 8.3%, extraperitoneal bladder perforation 4.2%, all managed conservatively. Histopathology: 100% urothelial carcinoma, stage T1, high grade 83.3%. The detrusor muscle-containing rate reached 87.5%. Good surgical outcome was 85.4%. Three-month recurrence-free rate was 95.2% (40/42 patients at follow-up). Conclusion: Our initial results suggest ERBT is a feasible technique with short operative time, low complication rate and good specimen quality, representing a valuable option for NMIBC treatment.

Article Details

References

1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3): 209-249.
2. Babjuk M, Burger M, Capoun O et al (2022) European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol 81(1): 75-94.
3. Brausi M, Collette L, Kurth K et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder. Eur Urol 41(5): 523-531.
4. Yanagisawa T, Sato S, Hayashida Y et al (2023) Comparison of en bloc resection versus conventional transurethral resection of bladder tumor: A systematic review and meta-analysis. World J Urol 41(7):1741-1752.
5. Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder: A prospective multicentre study. World J Urol 33(12): 1937-1943.
6. Migliari R, Buffardi A, Ghabin H (2015) Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol 29(11): 1258-1262.
7. Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS. Eur Urol 74(3): 294-306.
8. Đỗ Ngọc Thể, Nguyễn Đức Anh, Lê Trường Sơn (2025) Kết quả phẫu thuật nội soi qua niệu đạo cắt u bàng quang nguyên khối điều trị u bàng quang nông tại Bệnh viện Trung ương Quân đội 108. Tạp chí Y Dược lâm sàng 108, 20(2).
9. Nguyễn Phúc Cẩm Hoàng, Nguyễn Thanh Mộng, Trần Trọng Huân (2021) Ưu điểm của phương pháp cắt đốt nội soi lấy nguyên khối bướu bàng quang bằng điện lưỡng cực. Tạp chí Y học Thành phố Hồ Chí Minh 25(1): 195-199.